Skip to main content
. 2022 Dec 12;14(24):6115. doi: 10.3390/cancers14246115
5fC 5-formylcytosine
ALK anaplastic lymphoma kinase gene
BRAF human gene that encodes a protein called B-Raf
CA-125 cancer/ carcinoma antigen 125, or carbohydrate antigen 125
CEA carcinoembryonic antigen
cfDNA cell-free DNA
cfRNA cell-free RNA
CHIP clonal hematopoiesis of indeterminate potential
CI confidence interval
CpG dinucleotide DNA where a cytosine (C) nucleotide is followed by a guanine (G) nucleotide
CRC colorectal cancer
CRPC castrate-resistant prostate cancer
CSC cancer stem cell
CSF cerebrospinal fluid
CTC circulating tumor cell
ctDNA circulating tumor-derived DNA
DELFI DNA evaluation of fragments for early interception
DFS disease-free survival
DNA deoxyribonucleic acid
EC endometrial cancer
EGFR epidermal growth factor receptor
ER estrogen receptor
ESMO European Society for Medical Oncology
ET end of treatment
EV extracellular vesicle
FDA Food and Drug Administration
FTV functional tumor volume
HER2 human epidermal growth factor receptor 2
HR hazard ratio
ICB immune checkpoint blockade
KRAS “Kirsten rat sarcoma virus” is a gene that provides instructions for making a protein called K-Ras
LB liquid biopsy
mAb monoclonal antibody
MRD minimal residual disease
mRNA messenger RNA
MSI microsatellite instability
MT middle of thetherapy
mtDNA mitochondrial DNA
NAT neoadjuvant therapy
NCCN National Comprehensive Cancer Network
NCDB National Cancer Database
NGS next-generation sequencing
NSCLC non-small-cell lung cancer
OC ovarian cancer
OR odds ratio
OS overall survival
PCR polymerase chain reaction
PFS progression-free survival
PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
PSA prostate-specific antigen
RFS relapse-free survival
RNA ribonucleic acid
RT radiotherapy
SCLC small cell lung cancer
TEP tumor-educated platelets
TET ten-eleven translocation enzyme
TKI tyrosine kinase inhibitor
TMB tumor mutational burden
TNBC triple-negative breast cancer
TP53 tumor protein p53
VAF variant allele frequency